Electrophysiological Biomarkers for Parkinson's Disease


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Scottsdale/Phoenix, Arizona: 11-002328
    Sponsor Protocol Number: 11-002328

About this study

This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Subjects must be enrolled in the Banner-Sun Health Brain and Body donation program and request to have there electrophysiological testing for the program at Mayo Clinic Hospital in Phoenix rather than farther away in Sun City.

Exclusion Criteria: 

  • Subjects not in inclusion criteria and who cannot travel to Mayo Clinic Hospital.


Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

John Caviness, M.D.

Contact us for the latest status

Contact information:

John Caviness M.D.